Explore

Capbase

Portal Biotechnologies, Inc. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

$11.7MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Portal Biotechnologies, Inc. filed a Form D notice of exempt offering with the SEC.

2 rounds

No investors recorded yet for Portal Biotechnologies, Inc..

Leadership

Armon ShareiExecutive OfficerSince 2026Source: [SEC]

Alec BarlcayExecutive Officer · Chief Technology OfficerSince 2026Source: [SEC]

Portal Biotechnologies, Inc. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Portal Biotechnologies, Inc..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Source:

$9M

—post-money